# Pharmaceutical GxP is not one regulation — it is a family of regulations that govern every phase of drug development, manufacturing, and distribution. GMP (Good Manufacturing Practice) governs production and qual... ## Pharmaceutical Software Development: GxP & Clinical Systems Custom GxP-compliant software for pharmaceutical manufacturers, CROs, and biotech companies — from clinical trial data management and electronic batch records to DSCSA serialization and LIMS integration. Every system built to FDA 21 CFR Part 11, EU Annex 11, and GAMP 5 standards with full Computer System Validation documentation. Average drug development costs $2.6 billion and takes 10–15 years. The software that supports that pipeline cannot be an afterthought. --- ## Key Stats - **$2.6B**: average cost to develop a single new drug through FDA approval - **10–15 yrs**: typical drug development timeline from discovery to market - **90%**: of drugs entering Phase I clinical trials never reach approval - **3.6M**: average data points generated per Phase III clinical trial - **1–5%**: transcription error rate in paper-based pharmaceutical batch records - **40–60%**: CSV burden reduction with validation-aware development practices --- ## Frequently Asked Questions ### What does FDA 21 CFR Part 11 actually require for pharmaceutical software? 21 CFR Part 11 establishes the criteria under which FDA considers electronic records and electronic signatures to be trustworthy and equivalent to paper records and handwritten signatures. For pharmaceutical software, the practical requirements fall into three categories. First, audit trails: the system must record every creation, modification, or deletion of a regulated record, capturing the who (user identity), what (field changed, previous value, new value), when (server-generated timestamp), and why (reason for change, where required by your SOPs). Audit trails must be computer-generated, cannot be modified by users, and must be available for FDA review throughout the record retention period. Second, electronic signatures: each signature must include at least two distinct identification components (typically user ID plus password), must display the signer's printed name, the date and time, and the meaning of the signature (e.g., approval, review, verification), and must be linked to the specific record version being signed such that the record cannot be altered without invalidating the signature. Third, system controls: the system must enforce role-based access, automatic session logoff, password policies, and device checks to ensure that only authorized individuals can access, modify, or sign records. These are not features to add in a future release — they must be part of the system architecture from the beginning. ### How does Computer System Validation (CSV) work for custom pharmaceutical software? CSV for custom (GAMP 5 Category 5) pharmaceutical software follows the V-model lifecycle. On the left side of the V, you define requirements at increasing levels of detail: the Validation Plan establishes scope and approach, the User Requirements Specification (URS) captures what the system must do from the user's perspective, the Functional Requirements Specification (FRS) details how each user requirement will be implemented, and the Design Specification (DS) documents the technical architecture. On the right side of the V, each specification level has a corresponding qualification: Installation Qualification (IQ) verifies the system is installed correctly in the target environment and matches the DS, Operational Qualification (OQ) verifies each function operates according to the FRS, and Performance Qualification (PQ) verifies the system performs as intended under realistic conditions as defined in the URS. A traceability matrix links every requirement to its test case and test result, ensuring complete coverage with no gaps. FreedomDev builds validation into the development workflow — requirements are traceable in our project management system, test scripts are written alongside code, and qualification protocols are executed in validated environments. This approach delivers the system and its complete validation package simultaneously, rather than treating validation as a separate project that delays deployment by months. ### What is the difference between GAMP 5 software categories, and why does it matter for our project? GAMP 5 defines five software categories that determine the validation effort required. Category 1 is infrastructure software — operating systems, database engines, network components — that requires only installation verification and configuration documentation. Category 3 is non-configured commercial software used as-is, which requires documented verification that it performs as expected in your environment. Category 4 is configured software — commercial platforms where you select functionality through configuration settings, templates, or workflows (examples: LabWare LIMS configured for your lab's methods, Veeva Vault configured for your document workflows). Category 4 requires validation of the configuration, including verification that configured workflows produce the intended results. Category 5 is custom software — built from scratch to meet your specific requirements. Category 5 requires the most rigorous validation because the code is unique and has no prior use history. When FreedomDev builds custom pharmaceutical software, it is a Category 5 system, and we deliver the full lifecycle documentation: URS, FRS, DS, traceability matrix, and IQ/OQ/PQ protocols. The category matters because it determines your validation budget and timeline — underestimating the category leads to validation gaps that FDA inspectors will find. ### How do we meet DSCSA serialization requirements if we are a contract manufacturer (CMO)? Contract manufacturers face a unique DSCSA challenge: you serialize products on behalf of multiple brand owners, each with their own serial number pools, NDC codes, trading partner networks, and data exchange requirements. Your serialization system must support multi-tenant operations — managing separate serial number ranges, label configurations, and aggregation hierarchies for each client while running on shared packaging line infrastructure. At the line level, you need the ability to switch between client configurations quickly during changeovers, with validation that the correct serial number pool, label template, and NDC code are loaded for each production run. At the enterprise level, you need a serialization repository that maintains client separation while giving your operations team a unified view of serialization status across all clients and lines. At the trading partner level, you must exchange EPCIS events with each client's designated distributors — which may mean supporting multiple VRS (Verification Router Service) connections and different EPCIS message formats. FreedomDev builds multi-tenant CMO serialization platforms that handle this complexity while maintaining the 21 CFR Part 11 audit trails and GS1 compliance that both your clients and FDA require. ### Can we integrate a new custom system with our existing Veeva, SAP, or LabWare platform? Yes, and integration with existing validated systems is how most of our pharmaceutical projects are structured. Very few pharmaceutical companies need a complete system replacement — they need custom capabilities that their existing platforms do not provide, integrated seamlessly with the systems that are already validated and in production. FreedomDev builds integration layers that connect to Veeva Vault (Quality, CDMS, RIM) via Vault REST API, to SAP via RFC/BAPI or OData services, to LabWare LIMS via LabWare's web services API, to Oracle systems via JDBC and REST, and to MasterControl and TrackWise via their respective integration interfaces. The critical requirement in pharmaceutical integration is maintaining GxP data integrity across system boundaries. Data flowing between systems must be audit-trailed at both ends, transformation logic must be validated and version-controlled, and the integration itself must be covered by your CSV documentation — including IQ/OQ testing of the integration interfaces. FreedomDev delivers integration validation documentation as part of every project, including interface specifications, data mapping documents, and qualification protocols specific to each connected system. ### What is the ALCOA+ framework, and how does it affect pharmaceutical software architecture? ALCOA+ is the data integrity framework that FDA, EMA, WHO, PIC/S, and MHRA use to evaluate whether pharmaceutical data — including electronic data in software systems — is trustworthy. The acronym stands for Attributable (every entry linked to the person who made it), Legible (readable and permanent), Contemporaneous (recorded at the time of the activity, not hours or days later), Original (the first-capture record, not a transcribed copy), and Accurate (correct, or if corrected, the original entry is preserved with a documented reason for change). The '+' adds Complete (all data present, including repeat tests and rejected results), Consistent (timestamps in logical sequence, no backdating), Enduring (stored on durable media with backup), and Available (retrievable for the entire retention period). For software architecture, ALCOA+ drives specific technical decisions. Attributable requires authenticated user sessions with server-side identity verification for every data entry. Contemporaneous requires server-generated timestamps that users cannot modify. Original requires that the first point of electronic capture is the system of record, with no intermediate transcription steps. Accurate requires append-only audit trails where corrections create new records referencing the original rather than overwriting it. These are not UI features — they are database schema decisions, API design patterns, and infrastructure requirements that must be established at the foundation of the system. --- ## GxP Compliance: GMP, GLP, GCP in Custom Software GxP is not one regulation — it is a family of regulations that govern every phase of drug development, manufacturing, and distribution. GMP (Good Manufacturing Practice) governs production and quality control of pharmaceutical products under 21 CFR Parts 210 and 211. GLP (Good Laboratory Practice) governs non-clinical laboratory studies under 21 CFR Part 58. GCP (Good Clinical Practice) governs clinical trials involving human subjects under ICH E6(R2). Each has distinct requirements for how software systems must behave, how data must be captured and stored, and how validation must be documented. A clinical trial EDC system operating under GCP has fundamentally different validation requirements than an electronic batch record system operating under GMP — and both differ from a LIMS operating under GLP. Software vendors who treat GxP as a single checkbox do not understand the regulatory landscape. FDA 21 CFR Part 11 establishes the criteria under which electronic records and electronic signatures are considered trustworthy, reliable, and equivalent to paper records and handwritten signatures. The rule applies to any electronic record that is created, modified, maintained, archived, retrieved, or transmitted under any FDA regulation. In practice, this means every pharmaceutical software system must implement audit trails that capture who changed what, when, and why — with the previous value preserved. Electronic signatures must use at least two distinct identification components (such as user ID and password), must be linked to their respective electronic records, and must include the printed name of the signer, the date and time of the signature, and the meaning of the signature (approval, review, responsibility). Session controls must ensure that only authorized individuals can use the system, with automatic logoff after periods of inactivity. These are not optional features to add later — they are foundational architectural requirements that must be designed into the system from the first line of code. GAMP 5 — Good Automated Manufacturing Practice version 5, published by ISPE — provides the risk-based framework for validating computerized systems in GxP-regulated environments. GAMP 5 categorizes software into five categories that determine the validation approach. Category 1 covers infrastructure software like operating systems and database engines. Category 3 covers non-configured products used as-is. Category 4 covers configured products where functionality is selected through configuration rather than custom code. Category 5 covers custom applications — bespoke software built to specific user requirements. Categories 4 and 5 require the most rigorous validation because they carry the highest risk of introducing errors specific to the regulated process. When FreedomDev builds pharmaceutical software, we are building Category 5 systems. That means full lifecycle validation: User Requirements Specification (URS), Functional Requirements Specification (FRS), Design Specification (DS), and a complete V-model testing approach with Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ). Every requirement traces forward to a test case and every test case traces back to a requirement. There are no gaps in the traceability matrix. Data integrity in pharmaceutical software is governed by the ALCOA+ principles, established by FDA and adopted globally by EMA, WHO, PIC/S, and MHRA. ALCOA+ requires that data be Attributable (who performed the action and when), Legible (readable and permanent throughout the retention period), Contemporaneous (recorded at the time of the activity), Original (the first-capture record or a certified true copy), and Accurate (free from errors, or if errors exist, they are documented with corrections that do not obscure the original entry). The '+' extends these principles to include Complete (all data including repeat or reanalysis results), Consistent (chronologically sequenced with timestamps that make sense), Enduring (recorded on permanent media, not whiteboards or sticky notes), and Available (accessible for review throughout the retention period). Every pharmaceutical software system FreedomDev builds enforces ALCOA+ at the database level — not as a policy overlay, but as a technical constraint that makes non-compliant data entry architecturally impossible. Audit trails are append-only. Original values are never overwritten. Timestamps are server-generated and cannot be modified by users. Signatures are cryptographically linked to the record content they attest to. --- ## Technologies - Veeva Vault (CDMS, Quality, RIM) - Medidata Rave - Oracle Argus - Oracle Clinical - LabWare LIMS - Thermo Fisher SampleManager - STARLIMS - SAP S/4HANA (Pharma) - MasterControl - TrackWise (Honeywell) - Antares Vision (Serialization) - Optel Group - Systech (Markem-Imaje) - EDMS (Documentum, Veeva Vault) - CDISC (CDASH, SDTM, ADaM) - GS1 / EPCIS - HL7 FHIR - REST APIs - PostgreSQL - Docker --- **Canonical URL**: https://freedomdev.com/industries/pharmaceutical _Last updated: 2026-05-14_